Know Cancer

or
forgot password

    • cancer clinical trials in sugar land, TX

    • Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Breast Cancer
    PhII ICb With/Without Erbitux in MBC Pts
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Metastatic Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Prostate Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Anal Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Breast Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Rectal Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Sunitinib Prog Met AIPC
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Metastatic Prostate Cancer
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Esophageal Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Androgen-independent Prostate Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Endometrial Cancer, Fatigue, Neurotoxicity
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Texas Oncology Cancer Center - Sugar Land
    Sugar Land, Texas 77479
    Urothelial Cancer
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Prostate Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Lung Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Texas Oncology - Sugar Land
    Sugar Land, Texas 77479
    Metastatic Breast Cancer
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Texas Oncology - Sugar Land
    Sugar Land, Texas 77479
    Advanced Prostate Cancer, Prostatic Neoplasms
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
    Biopharma Research Associates
    Sugar Land, Texas 77479
    Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Texas Oncology Cancer Center--Sugar Land
    Sugar Land, Texas 77479
    Carcinoma, Non-Small Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Colorectal Cancer Metastatic
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Texas Oncology Cancer Center--Sugar Land
    Sugar Land, Texas 77479
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Texas Oncology Cancer Center-Sugar Land
    Sugar Land, Texas 77479
    Metastatic Breast Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
    Sugar Land, Texas 77479
    Brain and Central Nervous System Tumors
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Texas Oncology Cancer Center - Sugar Land
    Sugar Land, Texas 77479
    Metastatic Breast Cancer
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840035
    Sugar Land, Texas 77055
    Venous Thromboembolism, Cancer